Increased DNA methylation variability in type 1 diabetes across three immune effector cell types

Nature Communications

Volumn 7, Issue , 2016, Pages

  Paul, Dirk S ^a,b   Teschendorff, Andrew E ^a,c   Dang, Mary A N ^d   Lowe, Robert ^d   Hawa, Mohammed I ^d   Ecker, Simone ^a   Beyan, Huriya ^d   Cunningham, Stephanie ^d   Fouts, Alexandra R ^e   Ramelius, Anita ^f   Burden, Frances ^g,h   Farrow, Samantha ^g,h   Rowlston, Sophia ^g,h   Rehnstrom, Karola ^g,h   Frontini, Mattia ^g,h,i   Downes, Kate ^g,h   Busche, Stephan ^j   Cheung, Warren A ^j   Ge, Bing ^j   Simon, Marie Michelle ^j   Bujold, David ^j   Kwan, Tony ^j   Bourque, Guillaume ^j   Datta, Avik ^k   Lowy, Ernesto ^k   Clarke, Laura ^k   Flicek, Paul ^k   Libertini, Emanuele ^a   Heath, Simon ^l,m   Gut, Marta ^l,m   Gut, Ivo G ^l,m   Ouwehand, Willem H ^g,h,i,n   Pastinen, Tomi ^j   Soranzo, Nicole ^g,n   Hofer, Sabine E ^o   Karges, Beate ^p,q   Meissner, Thomas ^q,r   Boehm, Bernhard O ^s,t,u   Cilio, Corrado ^f   Larsson, Helena Elding ^f   Lernmark, Åke ^f   Steck, Andrea K ^e   Rakyan, Vardhman K ^d   Beck, Stephan ^a   Leslie, R David ^d   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f LUND UNIVERSITY   (Sweden)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h NHS BLOOD AND TRANSPLANT   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j MCGILL UNIVERSITY   (Canada)

^k EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^l CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^m UNIVERSITAT POMPEU FABRA   (Spain)

ⁿ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^o INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^p RWTH AACHEN UNIVERSITY   (Germany)

^q GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^r UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^s UNIVERSITY HOSPITAL ULM   (Germany)

^t NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^u IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MAMMALIAN TARGET OF RAPAMYCIN;

BLOOD; CELLS AND CELL COMPONENTS; DIABETES; DNA; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; IMMUNE RESPONSE; METABOLISM; METHYLATION;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EFFECTOR CELL; EPIGENETICS; GENE REGULATORY NETWORK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; TWIN DISCORDANCE; UMBILICAL CORD BLOOD; FETUS BLOOD; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; TIME FACTOR;

CPG ISLANDS; DIABETES MELLITUS, TYPE 1; DNA METHYLATION; FETAL BLOOD; HUMANS; MOLECULAR SEQUENCE ANNOTATION; TIME FACTORS; TWINS, MONOZYGOTIC;

EID: 84999233015     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13555     Document Type: Article

References (72)

1. Bluestone, J. A., Herold, K. & Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464, 1293-1300 (2010).
2. Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A. & Soltész, G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373, 2027-2033 (2009).
3. Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69-82 (2014).
4. Redondo, M. J. et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44, 354-362 (2001).
5. Schübeler, D. Function and information content of DNA methylation. Nature 517, 321-326 (2015).
6. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
7. Michels, K. B. et al. Recommendations for the design and analysis of epigenome-wide association studies. Nat. Methods 10, 949-955 (2013).
8. Rakyan, V. K., Down, T. A., Balding, D. J. & Beck, S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529-541 (2011).
9. Paul, D. S. & Beck, S. Advances in epigenome-wide association studies for common diseases. Trends Mol. Med. 20, 541-543 (2014).
10. Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282-1293 (2015).
11. Allum, F. et al. Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants. Nat. Commun. 6, 7211 (2015).
12. Bell, J. T. et al. Differential methylation of the TRPA1 promoter in pain sensitivity. Nat. Commun. 5, 2978 (2014).
13. Hannon, E. et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19, 48-54 (2016).
14. Liu, Y. et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol. 31, 142-147 (2013).
15. Rakyan, V. K. et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet. 7, e1002300 (2011).
16. Stefan, M., Zhang, W., Concepcion, E., Yi, Z. & Tomer, Y. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J. Autoimmun. 50, 33-37 (2014).
17. Issa, J.-P. Epigenetic variation and cellular Darwinism. Nat. Genet. 43, 724-726 (2011).
18. Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-775 (2011).
19. Teschendorff, A. E. & Widschwendter, M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics 28, 1487-1494 (2012).
20. Teschendorff, A. E. et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 4, 24 (2012).
21. Teschendorff, A. E. et al. The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput. Biol. 10, e1003709 (2014).
22. Teschendorff, A. E. et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat. Commun. 7, 10478 (2016).
23. Castillo-Fernandez, J. E., Spector, T. D. & Bell, J. T. Epigenetics of discordant monozygotic twins: implications for disease. Genome Med. 6, 60 (2014).
24. Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288-295 (2011).
25. Dennis, M. D., McGhee, N. K., Jefferson, L. S. & Kimball, S. R. Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1). Cell Signal. 25, 2709-2716 (2013).
26. Teschendorff, A. E., Jones, A. & Widschwendter, M. Stochastic epigenetic outliers can define field defects in cancer. BMC Bioinformatics 17, 178 (2016).
27. Larsson, K. et al. Genetic and perinatal factors as risk for childhood type 1 diabetes. Diabetes Metab. Res. Rev. 20, 429-437 (2004).
28. Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492 (2012).
29. Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
30. Phipson, B., Maksimovic, J. & Oshlack, A. missMethyl: an R package for analysing methylation data from Illumina's HumanMethylation450 platform. Bioinformatics 32, 286-288 (2016).
31. Marbach, D. et al. Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat. Methods 13, 366-370 (2016).
32. The FANTOM Consortium and the RIKEN PMI and CLST (DGT). A promoter-level mammalian expression atlas. Nature 507, 462-470 (2014).
33. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
34. Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466-8471 (2003).
35. Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35 (2011).
36. Moran, A. et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381, 1905-1915 (2013).
37. Spaeth, J. M. et al. The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice. Diabetologia 58, 1836-1844 (2015).
38. Zou, Y. et al. Forkhead Box P1 (FOXP1) transcription factor regulates hepatic glucose homeostasis. J. Biol. Chem. 290, 30607-30615 (2015).
39. Tsai, P.-C. & Bell, J. T. Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation. Int. J. Epidemiol. 44, 1429-1441 (2015).
40. Moran, S., Arribas, C. & Esteller, M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 8, 389-399 (2016).
41. Visscher, P. M., Brown, M. A., McCarthy, M. I. & Yang, J. Five years of GWAS discovery. Am. J. Hum. Genet. 90, 7-24 (2012).
42. Olsson, A. H. et al. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet. 10, e1004735 (2014).
43. Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381-386 (2015).
44. Herold, K. C., Vignali, D. A. A., Cooke, A. & Bluestone, J. A. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat. Rev. Immunol. 13, 243-256 (2013).
45. Bluestone, J. A. et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189 (2015).
46. Zhao, M. et al. Increased 5-hydroxymethylcytosine in CD4+ T cells in systemic lupus erythematosus. J. Autoimmun. 69, 64-73 (2016).
47. Nestor, C. E. et al. 5-Hydroxymethylcytosine remodeling precedes lineage specification during differentiation of human CD4+ T cells. Cell Rep. 16, 559-570 (2016).
48. Heyn, H. et al. Linkage of DNA methylation quantitative trait loci to human cancer risk. Cell Rep. 7, 331-338 (2014).
49. Feng, X. et al. Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 115, 510-518 (2010).
50. Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112 (2009).
51. Cheng, S. C. et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
52. Ray, J. P. et al. The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43, 690-702 (2015).
53. Wei, H. et al. Foxp1 controls naive CD8+ T cell quiescence by simultaneously repressing key pathways in cellular metabolism and cell cycle progression. J. Immunol. 196, 3537-3541 (2016).
54. Chambers, J. C. et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 3, 526-534 (2015).
55. Soriano-Tárraga, C. et al. Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. Hum. Mol. Genet. 25, 609-619 (2016).
56. Hawa, M. I. et al. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 23, 228-233 (2000).
57. Wenzlau, J. M. et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl Acad. Sci. USA 104, 17040-17045 (2007).
58. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26, S5-S20 (2003).
59. Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450k DNA methylation data. Bioinformatics 29, 189-196 (2013).
60. Nordlund, J. et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14, R105 (2013).
61. Johnson, W. E. & Li, C. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).
62. Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882-883 (2012).
63. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440-9445 (2003).
64. Phipson, B. & Oshlack, A. DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging. Genome Biol. 15, 465 (2014).
65. Kulis, M. et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat. Genet. 47, 746-756 (2015).
66. Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353-1358 (2012).
67. Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 10, P10008 (2008).
68. Falcon, S. & Gentleman, R. Using GOstats to test gene lists for GO term association. Bioinformatics 23, 257-258 (2007).
69. Yu, G. & He, Q.-Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol. BioSyst. 12, 477-479 (2016).
70. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300 (1995).
71. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
72. Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091-1093 (2009).